A detailed history of High Mark Wealth Management LLC transactions in Scynexis Inc stock. As of the latest transaction made, High Mark Wealth Management LLC holds 1,066 shares of SCYX stock, worth $1,076. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,066
Previous 1,066 -0.0%
Holding current value
$1,076
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 20, 2023

SELL
$1.15 - $3.0 $616 - $1,608
-536 Reduced 33.46%
1,066 $3,000
Q3 2021

Nov 01, 2021

SELL
$5.3 - $7.89 $33,167 - $49,375
-6,258 Reduced 79.62%
1,602 $8,000
Q2 2021

Aug 02, 2021

BUY
$6.5 - $9.97 $17,745 - $27,218
2,730 Added 53.22%
7,860 $58,000
Q1 2021

Apr 22, 2021

BUY
$6.93 - $9.63 $11,088 - $15,408
1,600 Added 45.33%
5,130 $41,000
Q3 2020

Oct 26, 2020

BUY
$4.37 - $7.48 $15,426 - $26,404
3,530 New
3,530 $16,000

Others Institutions Holding SCYX

About SCYNEXIS INC


  • Ticker SCYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 32,651,800
  • Market Cap $33M
  • Description
  • SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...
More about SCYX
Track This Portfolio

Track High Mark Wealth Management LLC Portfolio

Follow High Mark Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Mark Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Mark Wealth Management LLC with notifications on news.